83 related articles for article (PubMed ID: 29771006)
1. The Antifibrotic Effect of A
Karmouty-Quintana H; Molina JG; Philip K; Bellocchi C; Gudenkauf B; Wu M; Chen NY; Collum SD; Ko J; Agarwal SK; Assassi S; Zhong H; Blackburn MR; Weng T
Arthritis Rheumatol; 2018 Oct; 70(10):1673-1684. PubMed ID: 29771006
[TBL] [Abstract][Full Text] [Related]
2. Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis.
Ruzehaji N; Avouac J; Elhai M; Frechet M; Frantz C; Ruiz B; Distler JH; Allanore Y
Arthritis Res Ther; 2015 May; 17(1):145. PubMed ID: 26025306
[TBL] [Abstract][Full Text] [Related]
3. Peripheral Hybrid CB
Zawatsky CN; Park JK; Abdalla J; Kunos G; Iyer MR; Cinar R
Front Endocrinol (Lausanne); 2021; 12():744857. PubMed ID: 34650521
[TBL] [Abstract][Full Text] [Related]
4. Role of STAT3 in skin fibrosis and transforming growth factor beta signalling.
Pedroza M; To S; Assassi S; Wu M; Tweardy D; Agarwal SK
Rheumatology (Oxford); 2018 Oct; 57(10):1838-1850. PubMed ID: 29029263
[TBL] [Abstract][Full Text] [Related]
5. Antifibrotic effect of apremilast in systemic sclerosis dermal fibroblasts and bleomycin-induced mouse model.
Higuchi T; Takagi K; Tochimoto A; Ichimura Y; Hirose H; Sawada T; Shibata N; Harigai M; Kawaguchi Y
Sci Rep; 2023 Nov; 13(1):19378. PubMed ID: 37938601
[TBL] [Abstract][Full Text] [Related]
6. Effect of Anti-S100A4 Monoclonal Antibody Treatment on Experimental Skin Fibrosis and Systemic Sclerosis-Specific Transcriptional Signatures in Human Skin.
Trinh-Minh T; Györfi AH; Tomcik M; Tran-Manh C; Zhou X; Dickel N; Tümerdem BS; Kreuter A; Burmann SN; Borchert SV; Hussain RI; Hallén J; Klingelhöfer J; Kunz M; Distler JHW
Arthritis Rheumatol; 2024 May; 76(5):783-795. PubMed ID: 38108109
[TBL] [Abstract][Full Text] [Related]
7. S100A4-neutralizing monoclonal antibody 6B12 counteracts the established experimental skin fibrosis induced by bleomycin.
Švec X; Štorkánová H; Trinh-Minh T; Tran MC; Štorkánová L; Hulejová H; Oreská S; Heřmánková B; Bečvář R; Pavelka K; Vencovský J; Klingelhöfer J; Hussain RI; Hallén J; Šenolt L; Distler JHW; Tomčík M
Rheumatology (Oxford); 2024 Mar; 63(3):817-825. PubMed ID: 37314987
[TBL] [Abstract][Full Text] [Related]
8. Skin and lung fibrosis induced by bleomycin in mice: a systematic review.
Gülle S; Çelik A; Birlik M; Yılmaz O
Reumatismo; 2024 Mar; 76(1):. PubMed ID: 38523580
[TBL] [Abstract][Full Text] [Related]
9. Deletion of adipocyte Sine Oculis Homeobox Homolog 1 prevents lipolysis and attenuates skin fibrosis.
Wareing N; Mills TW; Collum S; Wu M; Revercomb L; Girard R; Lyons M; Skaug B; Bi W; Ali MA; Koochak H; Flores AR; Yang Y; Zheng WJ; Swindell W; Assassi S; Karmouty-Quintana H
bioRxiv; 2024 May; ():. PubMed ID: 38826482
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine alleviates pulmonary fibrosis through the ADORA2B-Mediated MAPK signaling pathway.
Lai X; Lin Y; Huang S; Pu L; Zeng Q; Wang Z; Huang W
Respir Res; 2023 Aug; 24(1):214. PubMed ID: 37644529
[TBL] [Abstract][Full Text] [Related]
11. Enhancing Extracellular Adenosine Levels Restores Barrier Function in Acute Lung Injury Through Expression of Focal Adhesion Proteins.
Wang W; Chen NY; Ren D; Davies J; Philip K; Eltzschig HK; Blackburn MR; Akkanti B; Karmouty-Quintana H; Weng T
Front Mol Biosci; 2021; 8():636678. PubMed ID: 33778007
[No Abstract] [Full Text] [Related]
12. [Research advances on the role of aerobic glycolysis in skin fibrosis diseases].
Zhang LX; Hu DH
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2024 Apr; 40(4):389-394. PubMed ID: 38664034
[TBL] [Abstract][Full Text] [Related]
13. Intravenous immunoglobulins improve skin fibrosis in experimental models of systemic sclerosis.
Speca S; Farhat MM; Jendoubi M; Guerrier T; Sanges S; Staumont-Sallé D; Hachulla E; Dubucquoi S; Sobanski V; Collet A; Launay D
Sci Rep; 2023 Sep; 13(1):15102. PubMed ID: 37700078
[TBL] [Abstract][Full Text] [Related]
14. Alternative adenosine Receptor activation: The netrin-Adora2b link.
Yuan X; Mills T; Doursout MF; Evans SE; Vidal Melo MF; Eltzschig HK
Front Pharmacol; 2022; 13():944994. PubMed ID: 35910389
[TBL] [Abstract][Full Text] [Related]
15. Nuclear IL-33 in Fibroblasts Promotes Skin Fibrosis.
Park JH; Mortaja M; Azin M; Nazarian RM; Demehri S
J Invest Dermatol; 2023 Jul; 143(7):1302-1306.e4. PubMed ID: 36708946
[No Abstract] [Full Text] [Related]
16. Correction: Štorkánová et al. Inhibition of Hsp90 Counteracts the Established Experimental Dermal Fibrosis Induced by Bleomycin.
Štorkánová H; Štorkánová L; Navrátilová A; Bečvář V; Hulejová H; Oreská S; Heřmánková B; Špiritović M; Bečvář R; Pavelka K; Vencovský J; Distler JHW; Šenolt L; Tomčík M
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893244
[TBL] [Abstract][Full Text] [Related]
17. Blockade of CCL24 with a monoclonal antibody ameliorates experimental dermal and pulmonary fibrosis.
Mor A; Segal Salto M; Katav A; Barashi N; Edelshtein V; Manetti M; Levi Y; George J; Matucci-Cerinic M
Ann Rheum Dis; 2019 Sep; 78(9):1260-1268. PubMed ID: 31129606
[TBL] [Abstract][Full Text] [Related]
18. Allele-specific expression reveals genetic drivers of tissue regeneration in mice.
Mack KL; Talbott HE; Griffin MF; Parker JBL; Guardino NJ; Spielman AF; Davitt MF; Mascharak S; Downer M; Morgan A; Valencia C; Akras D; Berger MJ; Wan DC; Fraser HB; Longaker MT
Cell Stem Cell; 2023 Oct; 30(10):1368-1381.e6. PubMed ID: 37714154
[TBL] [Abstract][Full Text] [Related]
19. Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidence.
Kumar K; Singh N; Yadav HN; Maslov L; Jaggi AS
Curr Cardiol Rev; 2023; 19(6):56-71. PubMed ID: 37309766
[TBL] [Abstract][Full Text] [Related]
20. A2B Adenosine Receptor in Idiopathic Pulmonary Fibrosis: Pursuing Proper Pit Stop to Interfere with Disease Progression.
Effendi WI; Nagano T
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
